An antibody–cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours
European Journal of Cancer2011Vol. 47(11), pp. 1736–1746
Citations Over TimeTop 15% of 2011 papers
Rebecca K. Kelly, Dian L. Olson, Yaping Sun, Dingyi Wen, Kathleen Wortham, Giovanna Antognetti, Anne E. Cheung, Olivia Orozco, Yang Lü, Véronique Bailly, Michele Sanicola
Related Papers
- → BR96 conjugates of highly potent anthracyclines(2003)21 cited
- → Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208(1989)9 cited
- [Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11].(2003)
- [Application of monoclonal antibody for cancer therapy].(1994)
- → Experimental study on antitumor effect of monoclonal anti-idiotypic antibody-DNR conjugate to leukemia(1995)